Oncology & Cancer

FDA clears biomarker test for ovarian cancer

Approval last week by U.S. Food and Drug Administration (FDA) clears the path for nationwide use of tools that show the greatest specificity in estimating the risk of ovarian cancer in women with a pelvic mass.

Oncology & Cancer

Study finds more effective approach against ovarian cancer

In a recent issue of Cancer Research, Daniel J. Powell, Jr., PhD, a research assistant professor of Pathology and Laboratory Medicine and Obstetrics and Gynecology at the Perelman School of Medicine at the University of Pennsylvania, ...

Health

Newborn Apgar score related to teen school performance

(Medical Xpress) -- According to a new study published in Obstetrics and Gynecology, the Apgar test which is given to newborns one minute and five minutes after birth to evaluate their health is also an indicator of how they ...

page 27 from 34